Browsing Tag
United States
338 posts
Inside Walmart’s AI play: How ChatGPT could soon start shopping for you
Discover how Walmart and OpenAI are reinventing retail through proactive, AI-driven shopping that predicts what you need before you ask.
Amazon’s new pharmacy kiosks let you skip the drugstore line — Here’s how they work inside One Medical clinics
Amazon Pharmacy’s new in-clinic kiosks promise prescriptions in minutes. Find out how this move could redefine US pharmacy models.
How AstraZeneca’s $4.5bn Virginia investment aligns with Trump-era tariffs and U.S. supply chain policy
Find out how AstraZeneca’s $4.5 billion Virginia API plant could reshape global pharma supply chains and investor sentiment in 2025.
15m shares up for grabs — Is Intelligent Group signaling insider exit or just liquidity management?
Find out why Intelligent Group’s 15 million share sale filing could impact its NASDAQ stock and what it means for investor sentiment and liquidity today.
Inside the CDC purge: Why mass firings in America’s top health agency could reshape public safety
Mass firings at CDC deepen U.S. shutdown chaos—see how health surveillance, global response, and disease defense face unprecedented disruption.
Ørsted’s $9.35bn rescue plan: Can the offshore wind pioneer weather America’s energy politics?
Find out how Ørsted’s $9.35B rights issue aims to rescue its U.S. offshore wind projects and whether it can withstand America’s shifting energy politics.
Washington goes mining: Trilogy Metals doubles after U.S. seizes 10% stake and revives Alaska’s Ambler Road
The U.S. government takes a 10% stake in Trilogy Metals and approves the Ambler Road—find out how this move reshapes Alaska’s mining future.
Why Cipher Mining’s CFO change matters: Greg Mumford takes charge as Ed Farrell steps aside
Cipher Mining (NASDAQ: CIFR) names Greg Mumford as CFO replacing Ed Farrell — find out how this leadership change could reshape its Bitcoin mining and HPC strategy.
Toddlers get a breakthrough eczema treatment as FDA clears Arcutis’ ZORYVE cream 0.05%
Find out how Arcutis’ FDA-approved ZORYVE 0.05% cream is reshaping the pediatric eczema market and investor confidence in 2025.
Faraday Future finalizes FX 4 U.S. assembly plan as YT Jia outlines the company’s first volume-market EV strategy
Faraday Future unveils the FX 4 product execution plan and finalizes U.S. assembly, signaling its bold entry into the volume-market EV race.